Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD)

NCT02702817 is registered in ClinicalTrials.gov with Douglas Mental Health University Institute as lead sponsor.

NCT NCT02702817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02702817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigations of Naproxen Treatment Effects in Pre-clinical Alzheimer's Disease (INTREPAD)
Lead sponsor
Douglas Mental Health University Institute
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2012
Completion date
July 15, 2017
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, cognitive decline due to alzheimer disease, mild cognitive impairment due to alzheimer disease